IDG Leads in Vaccines Development
04 Jul 2024
US$ 19.00
IDG Capital has led in the over Rmb300 million (US$41.3 million) series C+ funding round of Chengdu Maxvax ......
Related Publications
Subscribers’ Weekly for the week ending 6 March 2026...
Listen to Subscribers' Weekly 06 Mar 2026...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.